These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 8985295

  • 41. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, Gelatti U, Bucella E, Tomasi E, Portolani N, Bonetti M, Bettini L, Pelizzari G, Salmi A, Savio A, Garatti M, Callea F.
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [Abstract] [Full Text] [Related]

  • 42. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 43. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF, Jeng LB, Lee WC, Chen TC.
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E.
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
    Lin TM, Chen CJ, Lu SN, Chang AS, Chang YC, Hsu ST, Liu JY, Liaw YF, Chang WY.
    Anticancer Res; 1991 May; 11(6):2063-5. PubMed ID: 1663719
    [Abstract] [Full Text] [Related]

  • 49. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
    Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, Nishiguchi S, Kinoshita H.
    Surg Today; 2004 May; 34(10):842-8. PubMed ID: 15449154
    [Abstract] [Full Text] [Related]

  • 50. Etiology of hepatocellular carcinoma in Africa.
    Olweny CL.
    IARC Sci Publ; 1984 May; (63):89-95. PubMed ID: 6100289
    [Abstract] [Full Text] [Related]

  • 51. Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand.
    Tangkijvanich P, Suwangool P, Mahachai V.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S250-6. PubMed ID: 12929997
    [Abstract] [Full Text] [Related]

  • 52. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, Wang J, Wu Y, Liu G, Wu Y, Zhu Y.
    Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
    [Abstract] [Full Text] [Related]

  • 53. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A.
    Intervirology; 2007 Aug; 50(4):241-4. PubMed ID: 17446712
    [Abstract] [Full Text] [Related]

  • 54. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T.
    Anticancer Res; 2001 Aug; 21(4B):2937-40. PubMed ID: 11712790
    [Abstract] [Full Text] [Related]

  • 55. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA.
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [Abstract] [Full Text] [Related]

  • 56. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.
    Sakamoto M, Hirohashi S, Tsuda H, Ino Y, Shimosato Y, Yamasaki S, Makuuchi M, Hasegawa H, Terada M, Hosoda Y.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7294-7. PubMed ID: 2847867
    [Abstract] [Full Text] [Related]

  • 57. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk.
    Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ.
    Hepatology; 2003 Dec 15; 38(6):1393-400. PubMed ID: 14647050
    [Abstract] [Full Text] [Related]

  • 58. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
    Koike K.
    Nihon Rinsho; 1999 Jan 15; 57(1):213-9. PubMed ID: 10036965
    [Abstract] [Full Text] [Related]

  • 59. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
    Bréchot C, Minami M, De Mitri S, Paterlini P.
    Princess Takamatsu Symp; 1995 Jan 15; 25():199-209. PubMed ID: 8875625
    [Abstract] [Full Text] [Related]

  • 60. [Current status and therapeutic strategy for hepatocellular carcinoma].
    Unoura M, Adachi K, Kawai H, Inagaki Y, Kaneko S, Kobayashi K.
    Gan To Kagaku Ryoho; 1990 Apr 15; 17(4 Pt 1):608-14. PubMed ID: 2157367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.